Pliant Therapeutics
Latest round
- Series C
Last raised
- Mar 2020
Total raised
- $159M
Investors
- 15
About Pliant Therapeutics
Pliant Therapeutics, Inc.Founded in 2015 and headquartered in San Francisco, US, Pliant Therapeutics, Inc. focuses on creating therapies for fibrotic diseases.000 mn. The company was founded by Bernard Coulie, who serves as its CEO.Pliant Therapeutics is dedicated to developing therapies for fibrotic diseases, with a primary focus on two clinical-stage programs that involve the first oral, selective small molecule integrin inhibitors. These products aim to provide effective and safer treatment alternatives for various fibrotic conditions, serving healthcare providers, research institutions, and patients.730 mn.Pliant Therapeutics plans to advance its innovative therapies, focusing on new product launches in the coming years as clinical trials progress. The company is actively targeting expansion into new markets, particularly regions in Europe and Asia, by mid-2023.000 mn, will be allocated to support these initiatives, including further clinical development and market entry strategies.
Who invested in Pliant Therapeutics
15 investors across 3 rounds
See all investors in Pliant Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Pliant Therapeutics
Who invested in Pliant Therapeutics?
Pliant Therapeutics has 15 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Pliant Therapeutics raised?
Pliant Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Pliant Therapeutics last raise money?
Pliant Therapeutics's most recent round on record is a Series C, in Mar 2020.
What does Pliant Therapeutics do?
Pliant Therapeutics is a biotechnology company.
Where is Pliant Therapeutics headquartered?
Pliant Therapeutics is headquartered in San Francisco, US.
Which VCs invest in companies like Pliant Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Pliant Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Pliant Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.